Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouwman, L. H.
Right arrow Articles by Roep, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouwman, L. H.
Right arrow Articles by Roep, B. O.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:3002-3006, 2005
© 2005 by the American Diabetes Association, Inc.

Elevated Levels of Mannose-Binding Lectin at Clinical Manifestation of Type 1 Diabetes in Juveniles

Lee H. Bouwman1,2, Peter Eerligh2, Onno T. Terpstra1, Mohamed R. Daha3, Peter de Knijff4, Bart E.P.B. Ballieux5, G. Jan Bruining6, Arno R. van der Slik2, Anja Roos3, and Bart O. Roep2

1 Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands
2 Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands
3 Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands
4 Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands
5 Department of Clinical Chemistry, Leiden University Medical Center, Leiden, the Netherlands
6 Sophia Children’s Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands

Mannose-binding lectin (MBL) is a recognition molecule of the lectin pathway of complement and a key component of innate immunity. MBL polymorphisms have been described that are associated with MBL serum concentration, impaired function, and diabetic complications. We investigated 86 new-onset juvenile type 1 diabetic patients and compared these with their nondiabetic siblings and healthy unrelated control subjects. Polymorphisms of MBL exon 1 and promoter were determined, and serum concentration and MBL-complex activity were measured. Although the genetic polymorphisms of MBL were not different between patients and control subjects, MBL serum concentration as well as MBL complex activity was significantly higher in new-onset diabetic patients compared with their siblings matched for high-producing MBL genotypes (P = 0.0018 and P = 0.0005, respectively). The increase in MBL complex activity in high-MBL–producing patients could only partially be explained by high MBL production, as demonstrated by an increased MBL complex activity–to–MBL concentration ratio (P = 0.004). We conclude that MBL serum concentration and complex activity are increased in early- onset diabetic patients upon manifestation independently of genetic predisposition to high MBL production, indicating a possible role in the immunopathogenesis of type 1 diabetes, in addition to the adaptive islet autoimmunity.


Address correspondence and reprint requests to Dr. Bart O. Roep, Department of Immunohaematology and Blood Transfusion, E3-Q, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, Netherlands. E-mail: boroep{at}lumc.nl

Abbreviations: CRP, C-reactive protein; mAb, monoclonal antibody; MASP, mannose-binding lectin-associated serine protease; MBL, mannose-binding lectin; SNP, single nucleotide polymorphism


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
C. D. Collard, S. K. Shernan, A. A. Fox, T. Bernig, S. J. Chanock, W. K. Vaughn, K. Takahashi, A. B. Ezekowitz, P. Jarolim, and S. C. Body
The MBL2 'LYQA Secretor' Haplotype Is an Independent Predictor of Postoperative Myocardial Infarction in Whites Undergoing Coronary Artery Bypass Graft Surgery
Circulation, September 11, 2007; 116(11_suppl): I-106 - I-112.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Roos, M. R. Daha, J. v. Pelt, and S. P. Berger
Mannose-binding lectin and the kidney
Nephrol. Dial. Transplant., August 3, 2007; (2007) gfm524v1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.